A short paragraph about you (a brief bio, standout achievements, affiliations etc.) 

Dr Jieping Chen is anAttending physician at Sun Yat sen University Cancer Center. He is interest in diagnosis and treatment of gynecological benign and malignant tumors such as cervical cancer, endometrial cancer and ovarian tumors. He is the secretary of the Oncology Group of the Obstetrics and Gynecology Branch of Guangdong Medical Association. He is also a member of the Gynecological Oncology Committee of the Guangdong Health Management Association.

Diagnosis and treatment of gynecological benign and malignant tumors such as cervical cancer, endometrial cancer and ovarian tumors. Surgery, chemotherapy, and targeted therapy in ovarian cancer

2008-2013: Bachelor of Clinical Medicine, Sun Yat sen Medical College, Sun Yat sen University

2013-2016: Master's degree in Oncology from Sun Yat sen University

2016-2019: Doctorate in Oncology, Sun Yat sen University

2019-2022: Postdoctoral fellow, assistant researcher, resident physician at Sun Yat sen University Cancer Center

From 2022 to present: attending physician at Sun Yat sen University Cancer Center

1. Liu, S #;Zou, Q #;Chen, JP #;Yao, X;Guan, P;Liang, W;Deng, P;Lai, X;Yin, J;Chen, J;Chen, R;Yu, Z;Xiao, R;Sun, Y;Hong, JH;Liu, H;Lu, H;Chen, J;Bei, JX;Koh, J;Chan, JY;Wang, B;Kang, T;Yu, Q;Teh, BT;Liu, J;Xiong, Y;Tan, J*.Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer.[J].J Clin Invest.2021,131(20):

2. Chen, Jie Ping; Huang, Qi Dan; Wan, Ting; Tu, Hua; Gu, Hai Feng; Cao, Jun Ya; Liu, Ji Hong*; Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer, Journal of Ovarian Research, 2019, 12: 72.  

3. Deng, Chuang Zhong #; Chen, Jie Ping #; Guo, Sheng Jie; Wang, Yan Jun; Zhou, Qiang Hua; Li, Zai Shang; Yang, Xing Ping; Yu, Xing Su; Zhang, Zhen Feng; Zhou, Fang Jian; Han, Hui*; Yao, Kai*; CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression, World Journal of Urology, 2017, 35(8): 1213-1221.   

4. Chen, Jie Ping #; Yao, Kai #; Li, Zai Shang; Deng, Chuang Zhong; Wang, Liang Jiao; Yu, Xing Su; Liang, Pei Li; Xie, Qian Kun; Chen, Peng; Qin, Zi Ke; Ye, Yun Kin; Liu, Zhuo Wei; Zhou, Fang Jian; Zhang, Zhen Feng*; Han, Hui*; Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis, Oncotarget, 2016, 7(32): 51687-51698.  

5. Gu, Hai Feng#; Liu, Guo Chen#; Chen, Jie Ping; Li, Jun Yun; Zhang, Xin Ke; Liu, Zhi Min*; Tu, Hua*; Proposal for modified inguinofemoral lymphadenectomy derived from investigation of anatomic distribution of sentinel and metastatic nodes in vulvar cancer, Journal of Surgical Oncology，2020.

6. Li, Zai Shang#; Yao, Kai#; Li, Yong Hong; Chen, Jie Ping; Deng, Chuang Zhong; Zhao, Qi; Chen, Peng; Wang, Bin; Mi, Qi Wu; Liu, Zhuo Wei; Qin, Zi Ke; Han, Hui; Zhou, Fang Jian*; Clinical significance of preoperative C-reactive protein and squamous cell carcinoma antigen levels in patients with penile squamous cell carcinoma, BJU International, 2016, 118(2): 272-278.

7. Tu Hua, Liu Guo Cheng, Gu Hai Feng, Liu Zhi Ming, Xian Bing Na, Chen Jie Ping, Liu Jihong*. Impact of treatment modality on survival of FIGO stage IIb cervical cancer: a propensity-score matching analysis based on impact of treatment modality on survival of FIGO stage IIb cervical cancer: a propensity-score matching analysis based on surveillance, epidemiology, and end results database. Int J Gynecol Cancer 2020, 30: A13-A14.

8. Zhou QH, Han H, Lu JB, Liu TY, Huang KB, Deng CZ, Li ZS, Chen JP, Yao K, Qin ZK, Liu ZW, Li YH, Guo SJ, Ye YL, Zhou FJ, Liu RY*. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients. Cancer Commun 2020, 40(1): 3-15.

9.  Deng, Chuang Zhong#; Li, Zai Shang#; Guo, Sheng Jie#; Chen Peng#; Chen Xiao Feng; Zhou Qiang Hua; Chen Jie Ping, Yu, Xing Su, Wu, Xiao Liang, Ma, Wen Juan, Xie, Qian Kun, Ye, Yun Lin, Li, Yong Hong, Qin, Zi Ke, Liu, Zhuo Wei, Liu, Ran Yi, Zhang, Zhen Feng, Yao, Kai, Han, Hui, Zhou, Fang Jian. Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma.[J].Oncoimmunology.2017,6(2):e1269047

10. Zhou Qiang Hua, Deng Chuang Zhong, Li Zai Shang, Chen Jie Ping, Yao Kai, Huang Kang Bo, Liu Ting Yu, Liu Zhuo Wei, Qin Zi Ke, Zhou Fang Jian, Huang Wei, Han Hui, Liu Ran Yi*. Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines. Cell Death Dis. 2018 Jun 7;9(6):684.

11. Li Zai Shang#, Yao Kai#, Chen Peng, Wang Bin, Chen Jie Ping, Mi Qi Wen, Li Yong Hong, Liu Zhuo Wei, Qin Zi Ke, Zhou Fang Jian, Han Hui*. Modification of N staging systems for penile cancer: a more precise prediction of prognosis. Br J Cancer. 2015 May 26;112(11):1766-71.